Cost of dengue in Colombia: A systematic review
Alfonso J. Rodríguez-Morales,Eduardo López-Medina,Iván Arboleda,Jaime A. Cardona-Ospina,Jaime Castellanos,Álvaro A. Faccini-Martínez,Elaine Gallagher,Riona Hanley,Pio López,Salim Mattar,Carlos Eduardo Pérez,Randee Kastner,Humberto Reynales,Fernando Rosso,Jing Shen,Wilmer E. Villamil-Gómez,Marcela Fuquen
DOI: https://doi.org/10.1371/journal.pntd.0012718
2024-12-13
PLoS Neglected Tropical Diseases
Abstract:Dengue is hyperendemic in Colombia. It imposes a substantial economic burden on patients, caregivers, society, and the national health system. We intend to identify and synthesize the evidence regarding the economic burden of dengue in Colombia. A systematic review (PROSPERO CRD42021257985) of economic studies was performed. A comprehensive search was completed in PubMed, EMBASE, the Cochrane Library, the LILACS, and SciELO databases. Study selection and data extraction was made by two researchers. 160 records were identified. Of these, 14 studies were selected for data extraction. Direct medical cost of dengue is mainly represented by hospitalization (USD 823 to 1,754). The annual aggregated cost is near to USD 159.6 million, with ambulatory care (USD 90.1 million) and fatal cases (USD 30.7 million) representing 75% of the total cost. The aggregate indirect cost (due to loss in income while sick or as a caretaker) was USD 92.8 million. Vaccination seems to reduce the economic cost of dengue. Dengue financial burden could be challenging for low-income communities as those affected in Colombia. An integrated approach including vector control and the introduction of a vaccine for dengue has the potential to reduce the economic burden of the disease. Dengue fever is a significant public health concern globally. Colombia, like many other tropical and subtropical countries, faces the challenge of managing and mitigating the burden of dengue. We developed a systematic review of the costs of dengue in Colombia, and we believe our findings have the potential to inform public health policies and resource allocation. By analyzing the direct medical costs associated with dengue cases, including hospitalization, diagnostics, and treatment, policymakers can gain valuable insights into the resource requirements for managing and preventing the disease. We believe this information could be taken as an example for other countries with similar epidemiology and could help to prioritize targeted interventions to reduce the incidence of dengue, such as mosquito control programs, community awareness campaigns, and vaccination strategies. We concluded that: Dengue disproportionately affects the communities with low socioeconomic status, costs related to severe dengue are significantly higher than ambulatory cases, dengue leads to missed work and lost earnings due to death or disability, implementing vector control programs to combat dengue is costly, and introducing a dengue vaccine has the potential to reduce the economic burden.
tropical medicine,parasitology